EMD Serono Unveils New MAVENCLAD® Four-Year Data …
WEBSep 12, 2024 · EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced presentations showcasing the long-term safety profile, sustained efficacy data, and durable effect of MAVENCLAD® (cladribine) tablets in individuals with relapsing multiple sclerosis (RMS).
EMD Serono Presents New MAVENCLAD
WEBFeb 29, 2024 · In a post-hoc analysis, new data reveal evidence of cognitive benefit in RMS after the initial course of MAVENCLAD® (cladribine) tablets, with sustained cognitive improvement or stability observed at two years.
New MAVENCLAD 4-year data highlighting sustained efficacy - Merck
WEBSep 12, 2024 · Merck, a leading science and technology company, today announced presentations showcasing the long-term safety profile, sustained efficacy data, and durable effect of MAVENCLAD ® (cladribine tablets) in individuals with …
EMD Serono Advances Development Programs in Oncology …
WEBJun 3, 2022 · EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today provided an update on the progress of the company’s innovative oncology development pipeline focused on DNA damage biology.
Merck Unveils New MAVENCLAD® Four-Year Data Highlighting …
WEBMerck, a leading science and technology company, today announced presentations showcasing the long-term safety profile, sustained efficacy data, and durable effect of MAVENCLAD ® (cladribine...
EMD Serono Advances Oncology Portfolio and Pipeline with …
WEBROCKLAND, Mass., Sept. 14, 2020 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today announced more than 30 abstracts will be...
WEBHighly specific potential first-in-class immune modulator blocking the activation of Toll-like receptor (TLR)7 and TLR8, known to be activated in lupus. Initiation of Phase II studies in systemic lupus erythematosus (SLE) / cutaneous lupus erythematosus (CLE) in …
Announces Plans for New U.S. Healthcare HQ in Boston | Merck …
WEBNov 14, 2023 · Merck KGaA, Darmstadt, Germany, which operates its Healthcare business as EMD Serono in the U.S. and Canada, today announced that it plans to move its U.S. Healthcare headquarters, currently located in Rockland, Mass., to Boston’s Seaport district.
AI for Biologics – In Silico Sequence Assessment Using Multiple ...
WEBJan 25, 2023 · Associate Scientific Director, Antibody Discovery & Protein Engineering bei Merck Gruppe. Published Jan 25, 2023. + Follow. Please see this manuscript on our fully automated in silico pipeline...
Flávia Felix on LinkedIn: Head of New Product Planning & Portfolio ...
WEBFlávia Felix. U.S. and Global Communications @EMD Serono | PR strategist. 2w. I am proud to echo EMD Serono's commitment to raising awareness for this rare and often misunderstood condition....